Personal smart devices offer an unprecedented opportunity to identify, track, map, and communicate about COVID-19. But apps could pose privacy and security concerns.
May 13, 2020 Inside Sources
Erika Litvin Bloom (she/her) is a behavioral/social scientist at RAND Corporation. Her research is focused primarily on development and evaluation of treatments for tobacco and other substance use disorders. She also has broad interests in increasing effectiveness, access to, and uptake of substance use treatment; weight management; digital health and health care technology; and health behavior change theory and processes. She is currently the Co-Principal Investigator (PI) of a NIDA-funded Fast Track Small Business Innovation Research grant in which she is partnering with a small business on developing and testing a smartphone-delivered smoking cessation program with social gaming and financial incentive components. She is also the RAND site PI of an NIDCR-funded UG3 grant involving piloting and preparation for a future UH3 trial of nicotine replacement therapy sampling in dental practices. In other recent projects, she developed and tested a distress tolerance treatment for women who were concerned about gaining weight after quitting smoking (funded by a NIDA K23 grant) and a contingency management treatment targeting prevention of weight gain after smoking cessation (funded by the Rhode Island Foundation).